India to United States: Letrozole Export Trade Route
India has recorded 90 verified shipments of Letrozole exported to United States, representing a combined trade value of $2.7M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $29.5K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 63% of total export value with 55 shipments worth $1.7M USD. On the buying side, EVERSANA LIFE SCIENCES SERVICES LLC is the largest importer in United States with $933.2K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, NATCO PHARMA LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Letrozole corridor is one of India's established pharmaceutical export routes, with 90 shipments documented worth a combined $2.7M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's letrozole manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $29.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with letrozole's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #14 among India's top letrozole export destinations globally.
On the import side, key buyers of Indian letrozole in United States include EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICES,LLC, AUROBINDO PHARMA USA., INC, and 12 others. EVERSANA LIFE SCIENCES SERVICES LLC is the single largest importer with 23 shipments valued at $933.2K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ3
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#14
- Annual growth+20.0%
- Demand growth+17.1%
- Regulatory ease73/100
Top 10 Indian Letrozole Exporters to United States
Showing top 10 of 9 Indian suppliers exporting Letrozole to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $30.5K per shipment | 55 | $1.7M | 63.2% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $26.8K per shipment | 25 | $669.3K | 25.2% |
| 3 | NATCO PHARMA LIMITED Avg $249.4K per shipment | 1 | $249.4K | 9.4% |
| 4 | INTAS PHARMACEUTICALS LTD Avg $52.0K per shipment | 1 | $52.0K | 2.0% |
| 5 | AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED Avg $5.0K per shipment | 1 | $5.0K | 0.2% |
| 6 | KOIT BIOPHARMA PRIVATE LIMITED Avg $280 per shipment | 3 | $840 | 0.0% |
| 7 | OZAR CARE EXIM PRIVATE LIMITED Avg $72 per shipment | 1 | $72 | 0.0% |
| 8 | VEA IMPEX (I) PRIVATE LIMITED Avg $4 per shipment | 2 | $7 | 0.0% |
| 9 | ESR ENTERPRISES Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 9 Indian companies exporting letrozole to United States, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, NATCO PHARMA LIMITED, INTAS PHARMACEUTICALS LTD, AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, OZAR CARE EXIM PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, ESR ENTERPRISES. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 55 shipments worth $1.7M USD, giving it a 63% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Letrozole Importers in United States
Showing top 10 of 15 known buyers in United States receiving Letrozole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian letrozole in United States include EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICES,LLC, AUROBINDO PHARMA USA., INC,, BRECKENRIDGE PHARMACEUTICAL INC, AUROBINDO PHARMA USA INC, among 15 total buyers. The largest importer is EVERSANA LIFE SCIENCES SERVICES LLC, accounting for $933.2K USD across 23 shipments — representing 35% of all letrozole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES LLC | 23 | $933.2K | 35.1% |
| 2 | EVERSANA LIFE SCIENCES SERVICES,LLC | 20 | $642.3K | 24.2% |
| 3 | AUROBINDO PHARMA USA., INC, | 16 | $349.9K | 13.2% |
| 4 | BRECKENRIDGE PHARMACEUTICAL INC | 1 | $249.4K | 9.4% |
| 5 | AUROBINDO PHARMA USA INC | 4 | $205.3K | 7.7% |
| 6 | EVERSANA LIFE SCIENCES SERVICESLLC | 10 | $102.8K | 3.9% |
| 7 | 4580 S MENDENHALL ROAD MEMPHIS TN | 3 | $53.6K | 2.0% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 3 | $40.2K | 1.5% |
| 9 | AUROLOGISTICS LLC AUROBINDO PHARM | 1 | $40.1K | 1.5% |
| 10 | AUROBINDO PHARMA USA. INC | 1 | $33.9K | 1.3% |
Showing top 10 of 15 Letrozole importers in United States on this route.
Top 10 Letrozole Formulations Imported by United States
Showing top 10 of 37 product formulations shipped on the India to United States Letrozole route, ranked by trade value
United States imports a wide range of letrozole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI LETROZOLE TAB USP 2. — accounts for $262.8K USD across 8 shipments. There are 37 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI LETROZOLE TAB USP 2. | 8 | $262.8K | 9.9% |
| 2 | LETROZOLE TABLET USP 2.5 MG - BT 30'S | 1 | $249.4K | 9.4% |
| 3 | PHR DRUGS&MEDI LETROZOLE TAB USP 2.5 MG | 4 | $210.1K | 7.9% |
| 4 | PHARMA DRUGS & MEDI LETROZOLE TAB USP 2. | 4 | $181.4K | 6.8% |
| 5 | PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 90TUS-ACCO AS PER DOCUMENT | 3 | $157.1K | 5.9% |
| 6 | PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 30TUS-ACCO AS PER DOCUMENT | 3 | $154.7K | 5.8% |
| 7 | PHARMA DRUGS MEDI LETROZOLE TAB USP 2 5 MG 90T US ACCO AS PER INVOICE | 5 | $151.7K | 5.7% |
| 8 | PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 90T(US-ACCO AS PER INVOICE | 5 | $127.6K | 4.8% |
| 9 | PHARMA DRUGS MEDI LETROZOLE TAB USP 2 5 MG 30T US ACCO AS PER INVOICE | 3 | $88.8K | 3.3% |
| 10 | PHARMA DRUG&MED:LETROZOLE TAB USP 2.5 MG | 1 | $88.7K | 3.3% |
Showing top 10 of 37 Letrozole formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 24 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's letrozole exports to United States are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 55 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, NATCO PHARMA LIMITED — together account for 98% of total trade value on this route. The average shipment value of $29.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as letrozole tablet usp 2.5 mg - bt 30's and phr drugs&medi letrozole tab usp 2.5 mg, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCES SERVICES LLC is the largest importer with 23 shipments worth $933.2K USD — representing 35% of all letrozole imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.7M
- Avg. Shipment
- $29.5K
- Suppliers
- 9
- Buyers
- 15
- Transit (Sea)
- ~20 days
- Annual Growth
- +20.0%
Other Letrozole Routes
Letrozole — Export Intelligence Video
Visual overview of India's letrozole India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Letrozole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 90 shipments on this route.
Frequently Asked Questions — India to United States Letrozole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Letrozole to United States?
The leading Indian exporters of Letrozole to United States are INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, NATCO PHARMA LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 63% of total trade value on this route.
Q What is the total value of Letrozole exports from India to United States?
India exports Letrozole to United States worth approximately $2.7M USD across 90 recorded shipments. The average value per shipment is $29.5K USD.
Q Which ports does India use to ship Letrozole to United States?
The most active port of origin is MUNDRA SEA with 24 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to United States for Letrozole?
The average transit time for Letrozole shipments from India to United States is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Letrozole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.0% with demand growth tracking at 17.1%. The route is ranked #14 among India's top Letrozole export destinations globally.
Q How many suppliers are active on the India to United States Letrozole route?
There are currently 9 active Indian suppliers exporting Letrozole to United States. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 63% of total shipment value.
Q Who are the main importers of Letrozole from India in United States?
The leading importers of Indian Letrozole in United States include EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICES,LLC, AUROBINDO PHARMA USA., INC,, BRECKENRIDGE PHARMACEUTICAL INC, AUROBINDO PHARMA USA INC. EVERSANA LIFE SCIENCES SERVICES LLC is the largest buyer with 23 shipments worth $933.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Letrozole.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 15 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 90 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
90 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists